In this study, we assessed whether cellular therapy affected the levels of selected neurotrophins in patients undergoing application of autologous, BM-derived Lin− SPCs into the coronary artery in the acute phase of myocardial infarction. The gene discussed is BDNF; the disease is myocardial infarction.